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Abstract
We have investigated the pathogenicity of tsetse (Glossina pallidipes)-transmitted cloned strains of Trypanosoma brucei
rhodesiense in vervet monkeys. Tsetse flies were confirmed to have mature trypanosome infections by xenodiagnosis, after
which nine monkeys were infected via the bite of a single infected fly. Chancres developed in five of the nine (55.6%)
monkeys within 4 to 8 days post infection (dpi). All nine individuals were successfully infected, with a median pre-patent
period of 4 (range = 4–10) days, indicating that trypanosomes migrated from the site of fly bite to the systemic circulation
rapidly and independently of the development of the chancre. The time lag to detection of parasites in cerebrospinal fluid
(CSF) was a median 16 (range = 8–40) days, marking the onset of central nervous system (CNS, late) stage disease.
Subsequently, CSF white cell numbers increased above the pre-infection median count of 2 (range = 0–9) cells/ml, with a
positive linear association between their numbers and that of CSF trypanosomes. Haematological changes showed that the
monkeys experienced an early microcytic-hypochromic anaemia and severe progressive thrombocytopaenia. Despite a 3-
fold increase in granulocyte numbers by 4 dpi, leucopaenia occurred early (8 dpi) in the monkey infection, determined
mainly by reductions in lymphocyte numbers. Terminally, leucocytosis was observed in three of nine (33%) individuals. The
duration of infection was a median of 68 (range = 22–120) days. Strain and individual differences were observed in the
severity of the clinical and clinical pathology findings, with two strains (KETRI 3741 and 3801) producing a more acute disease
than the other two (KETRI 3804 and 3928). The study shows that the fly-transmitted model accurately mimics the human
disease and is therefore a suitable gateway to understanding human African trypanosomiasis (HAT; sleeping sickness).
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Introduction
In human African trypanosomiasis (HAT), the use of animal
models has contributed enormously to what is currently known
about the relationships between disease duration, parasite invasion
of different body systems and the potential of resultant host clinical
and biological changes as diagnostic and disease staging markers.
Several host-parasite model systems have been developed, based
on infection of various hosts with the livestock pathogen
Trypanosoma brucei brucei and to a lesser extent the human pathogens
T. b. rhodesiense and T. b. gambiense. Characterisation of these HAT
models shows that the disease occurs in two stages irrespective of
host: an early haemo-lymphatic trypanosome proliferation, and a
late central nervous system (CNS) infection, indicating that the
basic pattern is similar to the disease in humans. This is evidenced
by demonstration of trypanosomes, first in the haemo-lymphatic
system and later in the CNS of the mouse model with subsequent
cerebral pathology [1,2]. Models based on larger mammals such
as the chimpanzee T. b. rhodesiense model [3], the vervet monkey T.
b. rhodesiense model [4] and the sheep T. b. brucei model [5], also
follow a similar two-stage disease pattern. These, unlike rodents,
allow collection of cerebrospinal fluid (CSF) that has been used to
demonstrate elevation of white cell counts and total protein levels
as indicators of CNS stage disease [6].
The KETRI vervet monkey model has been reported to closely
mimic HAT clinically, immunologically and pathologically [4,7–9].
However, these previous studies were limited in scope in three
important ways. Firstly, infections were initiated by intravenous
inoculation (syringe) of bloodstream form trypanosomes as opposed
to the natural human disease, which begins via the bite of a tsetse fly,
with the intra-dermal inoculation of metacyclic trypanosomes. The
difference between the two routes of infection has the potential to
affect trypanosome virulence and subsequent disease pathogenesis
that has been little explored to date. Second, disease progression has
been monitored mainly in terms of clinical symptoms, gross
pathology, histo-pathology and antibody responses [4,7], with little
reference to the development of blood pathology. Third, only a
single strain of trypanosomes, KETRI 2537 [9], has been
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adequately characterised even though trypanosome strains vary in
the severity of pathogenesis and virulence [10–11].
The present study was designed to address these limitations and
thus improve further the potential utility of the model and our
understanding of pathogenesis in trypanosome infections. We
characterised the pathogenicity of T. b. rhodesiense in vervet
monkeys, following infection from the bite of a single tsetse fly,
hence mimicking the natural route of infection in man. This
allowed us to measure a range of parameters in blood and
cerebrospinal fluid (CSF) including several that had not previously
been studied. It was thus possible to measure the development of
clinical complications of HAT infections, such as anaemia, more
precisely. We describe the development of clinical pathology
resulting from infection with four cloned strains of T. b. rhodesiense.
Materials and Methods
Ethics
This study was undertaken in adherence to experimental
guidelines and procedures approved by the Institutional Animal
Care and Use Committee (IACUC), the ethical review committee
for the use of laboratory animals.
Selection of stock trypanosome isolates and cloning
Trypanosome isolates that were used in this study (Table 1) were
all initially obtained through collection of infected blood from
patients in the western Kenya/eastern Uganda focus of endemic T.
b. rhodesiense sleeping sickness (historically known as the Busoga
focus). All the isolates are maintained as cryo-preserved stabilates in
the KARI-TRC (formerly KETRI) trypanosome bank. The isolates
were included in the study on the basis of the year of isolation, to
give a wide temporal distribution and the locality of isolation to give
a wide spatial distribution within this sleeping sickness focus. The
selected stabilates were cloned using the hanging drop method
described by Herbert and Lumsden [12].
Tsetse fly infections
Male teneral tsetse flies (Glossina pallidipes) were obtained from
the KETRI colony initially established with pupae from the
Lambwe Valley of Kenya, which is part of the western Kenya/
eastern Uganda focus of HAT. In order to initiate infection of
tsetse flies with each trypanosome clone, four sub-lethally
irradiated (600 rads, 5 minutes) donor Swiss White mice were
each inoculated intraperitoneally with 0.2 millilitres of the thawed
T. b. rhodesiense stabilates, diluted in phosphate saline glucose
(PSG). At peak parasitaemia, typically approximately 108
trypanosomes per millilitre, a batch of 50 teneral flies were
allowed to feed essentially as described [13], and maintained
thereafter on clean bovine blood by feeding via a silicon
membrane. Thirty days after the infective blood meal, all the flies
were chilled briefly and separated into individual fly cages. The
flies with mature trypanosome infections were then identified by
xenodiagnosis using Swiss White mouse. We were repeatedly
unable to find trypanosomes in salivary probes on warm
microscope slides [14].
Experimental monkeys
Nine vervet monkeys (Chlorocebus aethiops, African Green
Monkeys) of both sexes weighing between 2.7 and 5.2 kg were
acquired from the Institute of Primate Research (IPR) in Kenya.
They were housed in quarantine for a minimum of 90 days while
being screened for evidence of disease, including zoonoses as
described by Ndung’u and colleagues [8]. They were also
dewormed and treated for any ectoparasite infestations. During
the quarantine period, the animals became accustomed to staying
in individual squeeze-back stainless steel cages and human
handling.
During quarantine and also while in the experimental animal
wards, the monkeys were maintained on green maize, fresh
vegetables (bananas, tomatoes and carrots) and commercial
monkey cubes (Monkey cubes, Unga Ltd, Kenya), fed twice daily
(9.00–9.30 am and 3.00–3.30 pm), and given water ad libitum.
After the expiry of the 90 days quarantine, the study animals were
then transferred to experimental wards and acclimatised for a
further two weeks prior to commencement of pre-infection data
collection.
Author Summary
Sleeping sickness is caused by a species of trypanosome
blood parasite that is transmitted by tsetse flies. To
understand better how infection with this parasite leads to
disease, we provide here the most detailed description yet
of the course of infection and disease onset in vervet
monkeys. One infected tsetse fly was allowed to feed on
each host individual, and in all cases infections were
successful. The characteristics of infection and disease
were similar in all hosts, but the rate of progression varied
considerably. Parasites were first detected in the blood 4–
10 days after infection, showing that migration of parasites
from the site of fly bite was very rapid. Anaemia was a key
feature of disease, with a reduction in the numbers and
average size of red blood cells and associated decline in
numbers of platelets and white blood cells. One to six
weeks after infection, parasites were observed in the
cerebrospinal fluid (CSF), indicating that they had moved
from the blood into the brain; this was associated with a
white cell infiltration. This study shows that fly-transmitted
infection in vervets accurately mimics human disease and
provides a robust model to understand better how
sleeping sickness develops.
Table 1. Temporal and geographic distribution of T. b. rhodesiense isolates and clones.
Year of
isolation geographic location Isolate lab. No. Comments Lab No. of derivative clone
1972 Busoga, Uganda KETRI 2537 Used in Schmidt and Sayer, (1982); five passages
since isolation, well characterised.
KETRI 3741
1989 Busia, Kenya KETRI 3199 One passage since isolation KETRI 3801
1989 Bukhayo West, Kenya KETRI 3205 Two passages since isolation KETRI 3804
2003 Tororo, Uganda KETRI 3928 One passage since isolation KETRI 3928
doi:10.1371/journal.pntd.0000238.t001
Cyclic Vervet Monkey Model for Sleeping Sickness
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Infections in monkeys
The monkeys were randomly allocated into four experimental
groups, each containing at least one male and one female, for
infection with T. b. rhodesiense clones as follows: KETRI 3741 (three
monkeys, #s. 476, 515, and 536), KETRI 3801 (monkey #s. 523,
579), KETRI 3804 (monkey #s 556 and 574) and KETRI 3928
(monkeys #s 554 and 555). Pre-infection (baseline) data was
collected over a period of 14 days after which each monkey was
infected by allowing one tsetse fly, confirmed trypanosome positive
through mouse infectivity tests, to feed on a shaved part of its
thigh, while the monkey was under ketamine Hcl (Rotexmedica,
Trittau Germany) anaesthesia. Before and following the infective
tsetse bite, the monkeys were monitored for activity, posture,
demeanour and general clinical presentation on a daily basis.
Appetite was assessed daily, by scoring the proportion of the daily
feed ration consumed by each monkey on a scale of 0 (no food
eaten), 1/4, 1/2, 3/4 and 1 (full ration eaten).
Parasitaemia was assessed daily using the method of Herbert
and Lumsden [12], using heparinised capillary blood drawn from
the ear vein, starting from the third day after infection. Every four
days, the monkeys were sedated using ketamine hydrochloride
(10–15 mg per kg body weight intramuscularly) after which a
detailed clinical examination was carried out and 2 ml of venous
blood (femoral) sampled for a full haemogram. Every eight days, a
CSF sample was also collected through lumbar puncture for
assessment of CNS parasitosis and white cell numbers. The
experiment was terminated through humane euthanasia at extremis.
An individual animal was judged to be in extremis when for three
consecutive days it was either unable or reluctant to perch, had
very low feed intake (,1/4 of daily ration), and in addition had
signs of advanced late stage disease (e.g somnolence). Euthanasia
was carried out using 20% pentobarbitone sodium (Euthatal,
Rhone Merieux).
Sample analysis
Cerebrospinal fluid white cell counts (WCC) and total trypano-
some numbers were concurrently counted using a Neubert chamber
as previously described [6,8]. Immediately after every sampling
session (not exceeding one hour), total red blood cell (RBC) and
related indices, white cell numbers and differential, platelet
(thrombocyte) counts and associated parameters were determined
using an AC3diff T Coulter counter (Miami, Florida, USA).
Data analysis
Data was entered and managed using Microsoft Excel (Version
2003). Statistical analysis was conducted using Statview for
Windows Version 5.0.1 (SAS Institute Inc, 1995–1998, Cary,
NC). The behaviour of the four trypanosome strains was analysed
and is presented as tables and or graphs representing time bound
changes in individual infected monkeys’ clinical, haematological
and cerebrospinal fluid pathology data. In addition, descriptive
statistics [mean (and the corresponding 95% confidence intervals,
CI), or medians and range] were derived for the entire group of nine
monkeys. In addition to derivation of descriptive data, haematology
data was further analysed using repeated measures ANOVA.
Finally, Spearman’s correlation coefficients were determined to
assess the strength of association between CSF trypanosome and
white cell numbers.
Results
Progression of infection in vervet monkeys
Parasitaemia. Following the bite of a single infected tsetse
fly, parasitaemia was detected in the peripheral blood of all nine
monkeys (Table 2), with an overall median pre-patent period of 4
(range= 4–10) days. The parasitaemia caused by all strains
increased rapidly (Figure 1), attaining peak levels of antilog 8.1–
8.4 trypanosomes/millilitre of blood within three to four days in
different individuals. Although there were subsequent fluctuations
(2–3 log scales), the parasitaemia levels remained high to very high
throughout the infection for all animals/strains (Figure 1).
However, slight differences were noted in the mean daily
parasitaemias for different individuals, with monkey 554 (strain
KETRI 3928) having lowest mean levels (antilog 6.8).
Clinical symptoms. Clinical symptoms of early stage HAT
included the classical trypanosome chancres (swellings 2–5 cm in
diameter with circumscribed erythematous margins), which
developed in five of the nine (55.6%) individuals (Table 2).
These swellings were detected by the fourth day and lasted up to
eight days post infection (dpi). Superficial lymph nodes (axillar and
inguinal) and splenomegally were enlarged in all monkeys, starting
4–12 dpi and 8–32 dpi respectively (Table 2). Raised hair coats,
lethargy, progressive weakness, intermittent fever and varying
degrees of weight loss were similarly observed in all individuals.
Anorexia was most marked in vervet monkeys infected with strains
KETRI 3741 and KETRI 3801. In these monkeys daily feed
intake reduced in comparison with the pre-infection period; in
vervet 523 feed intake was below 50% of daily ration in 11/21
(52.4%) days. Other clinical signs included muscle tremors/
fasciculation, seen only in monkey 579 (KETRI 3801) and
superficial oedema in 3/9 of the monkeys. Ataxia (inco-
ordination), hind leg paralysis and somnolence were observed in
a few individuals at extremis (Table 3), suggesting that the nervous
system was affected. The monkeys were euthanized humanely at
extremis with a median duration of infection of 68 (range = 21–
120) days.
Haematology. Anaemia was a key feature of the cyclic
infection in monkeys. During the first 32 dpi, red blood cell
(erythrocyte) counts and associated indices declined rapidly; the
magnitude of the decline in these parameters was most
pronounced in three monkeys infected with strains KETRI 3801
(523, 579) and KETRI 3741 (No 536) as shown (Table 3). In the
same period, the mean red blood cell count declined by 32.8%,
from a pre-infection value of 6.1 (95% CI=5.5–6.6) to 4.1 (95%
CI= 3.5–4.8; p,0.0001) million cells/ml of blood. The red cell
associated parameters exhibited similar trends, with the
haematocrit (HCT) declining from a pre-infection mean value of
47.4 (95% CI= 42.9–51.8) to 29.5 (95% CI=25.1–33.9,
p,0.0001). Similarly, the haemoglobin concentration declined
from a pre-infection mean value of 14.1 (95% CI= 12.7–15.6) to
9.1 (95% CI= 7.8–10.2) grams/decilitre (g/dl) of blood. As the
infection progressed, erythrocyte numbers and associated
parameters stabilised and actually improved slightly in two
monkeys (515 and 554, Table 3). At the terminal stage when the
monkeys were euthanized, the overall mean HCT was 23.5 (95%
CI= 18.3–28.7, p,0.0001) while the mean haemoglobin content
was 7.2 (95% CI= 5.4–9.0) g/dl.
The resultant anaemia was characterised by an overall
reduction in the average size of the red cells (the mean corpuscular
volume, MCV) and the mean corpuscular haemoglobin (MCH);
these changes were in contrast to the red cell distribution width
(RDW) which increased throughout the infection (Table 3,
Figure 2). Overall, the mean MCV declined significantly
(p = 0.0001), from a pre-infection (0 dpi) value of 78.2 (95%
CI= 76.4–80.1) to 71.6 (95% CI= 69.7–73.4) by 32 dpi. The
mean MCH declined more slowly; it took 52 days to decline
significantly (p = 0.007) from a pre-infection value of 23.4 (95%
CI= 22.4–24.4) to 20.6 (95% CI= 19.9–21.4) g/dl. Meanwhile,
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the mean RDW increased significantly (p = 0.0001) from a pre-
infection (0 dpi) value of 13.1 (95% CI= 12.3–13.8) to 19.2 (95%
CI= 17.5–20.9) by 32 dpi. Considered together, changes in MCV,
MCH and RDW indicate that: i) the monkeys suffered microcytic
hypochromic anaemia ii) the heterogenicity (anisocytosis) of the
erythrocyte population increased throughout the infection. In most
individuals, the MCV and MCH stabilised and, in vervet 556,
increased beyond pre-infection values in later stages of infection
(Table 3, Figure 3). These changes coincided with stabilisation or
improvement in erythrocyte numbers showing that in this small
number of individuals, the anaemia became regenerative.
The experimental cyclic disease was further characterised by a
marked thrombocytopenia. The pre-infection mean platelet count
was 350.4 (95% CI=297.4–403.5) platelets/ml of blood. Following
infection, platelets declined rapidly and progressively, reaching a
mean level of 161.6 (95% CI=94.3–228.8) platelets/ml of blood by
8dpi, which was a 53.9% drop. The sudden decrease in platelet
numbers was countered by a slightly delayed but similarly dramatic
increase in mean platelet volume (MPV). From a pre-infection mean
volume of 7.0 (95%CI=6.6–7.4) fl, theMPV increased by 25.7% to
a mean volume of 8.8 (95% CI=7.2–10.4) fl by 12 dpi and had
increased further to 9.7 (8.3–11.0), a 38.6 % increase by 32 dpi.
Early in the infection, the white blood cell (WBC) response
involved contrasting changes in the numbers of granulocytes and
lymphocytes in comparison with the pre-infection values. At 4 dpi,
granulocyte counts increased in all monkeys (except vervet 476) as
shown (Table 4). The mean granulocyte count rose three-fold,
from a pre-infection (0 dpi) mean value of 1.2 (95% CI=1.0–1.4)
to a mean value of 3.7 (95% CI= 1.5–6.0; p = 0.0002) cells/ml of
blood. In contrast, lymphocyte counts declined rapidly over the
same period (Table 4) and continued to be low well into the second
week of the infection. At 8 dpi, the mean count had declined by
57.5% from a pre-infection (0 dpi) value of 4.0 (95% CI= 2.8–
5.2)6103 to a mean value of 1.7 (95% CI= 0.9–2.5)6103 cells/ml
of blood at 8 dpi. This decline was significant (p = 0.0001).
Monocyte numbers decreased less convincingly, from a pre-
infection mean value of 1.3 (95% CI=0.7–2.0) to a mean value of
0.7 (95% CI=0.5–0.9)6103 cells/ml of blood at 8 dpi (p = 0.03).
All these changes resulted into an overall leucopaenia between 4–
12 dpi, the same period that trypanosomes were first detected in
peripheral blood in different monkeys. After the initial leucopae-
nia, multiple peaks of WBC were observed in all monkeys as
shown for vervet 554 (Figure 3). In very late stage infections,
overall leukocyte densities increased above pre-infection values
(leucocytosis) in 3/9 (33%) monkeys, largely determined by
changes in lymphocyte numbers (Table 4; Figure 3). In vervet
579 (KETRI 3801) however, granulocytes remained elevated
above pre-infection levels (and actually higher than lymphocyte
numbers) throughout the infection.
Cerebrospinal fluid (CSF) changes. The period to
penetration of parasites into the CSF varied between strains and
individual monkeys, with a range of 8–40 (overall median 16) days
(Table 2). Subsequently, parasite numbers and white cell counts
(WCC) became elevated, the increase in magnitude becoming
more severe as the infection progressed as shown for vervet 476
that was infected with clone KETRI 3741 (Figure 4). The changes
depicted in the vervet infection show a distinct early stage phase
that was characterised by localization of trypanosomes within the
haemo-lymphatic system, with no trypanosomes or pathological
changes in the CSF. Once the trypanosomes invaded the CSF, a
transition or ‘‘lag phase’’ was evident, characterised by low
trypanosome numbers in the CSF, with a median count of 1
[(range = 1–6); mean=1.6 (95% CI= 0.3–2.8)] trypanosomes/ml
and in vervet 476, lasted for about 14 days. Further WCC in CSF
were also moderately elevated, with a median count of 8
[(range = 0–41); mean=11 (95% CI= (1.6–20.4)] cells/ml, in
comparison with a pre-infection median count of 2 [range = 0–9;
mean=2.6 (95% CI= 0.6–5.1) cells/ml. The third phase, a severe
or true late stage disease phase was characterised by greatly
elevated numbers of CSF trypanosomes culminating in terminal
stage having a median count of 31 [range = 1–1620; mean= 296.7
(95% CI=0–700.4)] trypanosomes/ml of CSF. At the same time
the WCC were also further elevated with a median count of 14
[range = 7–46; mean= 23.7 (95% CI= 11.5–35.9) cells/ ml of
CSF. Overall, there was a positive linear association between
trypanosomes and WCC in the CSF (rs = 0.3244, p = 0.001).
Discussion
In this study, infection of vervet monkeys was initiated by the
bite of a single infected tsetse fly. To our knowledge, this represents
the first time single fly transmission of T. b. rhodesiense clones in
vervet monkeys (or any other primate model) has been achieved,
Figure 1. Parasitaemia curves generated by four T.b. rhode-
siense cloned strains after experimental fly (Glossina pallidipes)
infection of nine vervet monkeys (+-476,%-515, ¤-536, e-523,
&-579, m-556, x-574, N-554, n-555). After a variable pre-patent
period, the parasitaemia tended to plateau but with more clearly
defined waves of relapse and recrudescence in the individuals with
longer disease duration.
doi:10.1371/journal.pntd.0000238.g001
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hence establishing a model that more accurately mimics the
transmission of sleeping sickness as it occurs in humans.
Information on natural HAT relies on data provided in case
reports [15–16] and sometimes re-analysis of retrospective clinical,
epidemiological and pathology data [17–18]. Such data are
naturally limited on the questions of disease onset and duration as
there are only a small number of case reports in which the patient
could accurately remember the exact time of being bitten by a
tsetse fly [16,18]. In any case this is not readily accessible
information for inhabitants of endemic areas, where tsetse fly
challenge is continuous. This study has allowed us to generate
information on the pathogenesis of HAT in a manner that more
accurately mimics human disease, and facilitates documentation of
data from precise sampling points during the course of a tsetse
transmitted infection.
All four T. b. rhodesiense clones that were selected for this study
were successfully transmitted through tsetse flies in the initial step
of the model development protocol, a result that is consistent with
the very good vectorial capacity of G. pallidipes for both human and
animal trypanosomiasis in eastern Africa. Tsetse flies carrying
mature infections were identified by xenodiagnosis using Swiss
White mice. The pre-patent period in these mice (data not shown),
and subsequently in monkeys (Table 2), showed considerable
variation from host to host, consistent with observations in HAT
patients [18–19]. In contrast, mice and vervet monkeys that are
infected with T. b. rhodesiense via syringe passage show less variation
in pre-patent period [4], presumably because the inoculum in
these is usually well-defined, while tsetse flies are estimated to
inject 0–40,000 (mean, 3,200) infective metacyclics [20].
Trypanosomes were detected in 7 of the monkeys within 5 days
after infection (Table 2), indicating that the movement of
trypanosomes from the site of the fly bite to the systemic
circulation occurred quickly. This is remarkable, because it must
be associated with the transition from non-proliferating metacyc-
lics to rapidly dividing long slender bloodstream forms, clearly a
survival strategy for the parasites. This movement was indepen-
dent of the development of chancre, which was only observed in 5
monkeys. Chancres have been observed in HAT patients in whom
these swellings are estimated to occur within 5–15 days of an
infective fly bite [20], consistent with our data (Table 2). During
the formation of the chancre, the metacyclics transform to rapidly
dividing bloodstream form trypanosomes while the tissue at the
Table 3. Progressive changes in haematology indices of vervet monkeys infected with T.b. rhodesiense cloned strains through
cyclic (tsetse; Glossina pallidipes) transmission.
Parameters T.b. rhodesiense KETRI 3741
T.b. rhodesiense
KETRI 3801
T.b. rhodesiense.
KETRI 3804
T.b.rhodesiense KETRI
3928
a476F a515M a536M a523F a579M a556F a574M a554F a555M
Red blood cells (countsx106/ml): pre-infection level 5.21 5.71 6.35 6.16 6.28 5.48 6.51 5.39 7.34
Red blood cells: % reduction at 32dpi 23.4 25.7 53.5 48.9 44.4 29.7 26.7 21.3 24.8
Red blood cells: % reduction at extremis 55.9 15.4 53.5 49.0 71.4 52.2 13.2 57.9
Haematocrit (%): pre-infection level 40.6 46.6 51.4 48.3 48.3 40.2 52.1 41.7 57.2
Haematocrit (%): % reduction at 32 dpi 33.3 33.3 59.5 47.8 45.8 30.3 35.1 26.9 32.9
Haematocrit (%): % reduction at extremis 56.2 31.1 55.1 50.0 68.7 59.9 24.5 63.1
Haemoglobin (g/dl): Pre-infection level 12.2 14.3 16.4 14.2 14.2 11.8 15.2 12.1 16.9
Haemoglobin: % reduction at 32 dpi 25.4 31.5 57.3 45.8 45.1 30.5 34.9 24.8 32.0
Haemoglobin: % reduction at extremis 58.2 21.7 57.9 47.9 67.8 59.2 17.4 62.1
Mean corpuscular volume (fl): Pre-infection level 77.8 81.6 80.9 78.4 76.8 73.5 79.9 77.4 77.9
Mean corpuscular volume: % change at 32 dpi 212.6 29.9 212.6 +2.0 22.5 21.1 211.1 26.8 20.7
Mean corpuscular volume: % change at extremis 20.9 211.3 +1.1 21.6 +9.5 215.6 212.9 212.5
Mean corpuscular haemoglobin (pg): Pre-infection level 23.4 25.1 25.6 23.1 22.6 21.6 23.3 22.4 23.1
Mean corpuscular haemoglobin: % change at 32 dpi 23.0 28.0 27.8 +6.5 20.4 21.4 210.3 24.0 210.0
Mean corpuscular haemoglobin: % change at extremis 25.6 27.6 25.8 +2.7 +13.0 213.7 24.9 29.5
Red cell distribution width (%): pre-infection level 13.4 13.7 11.8 14.8 13.6 13.5 11.9 12.4 12.6
Red cell distribution width: % increase at 32 dpi 29.9 56.9 61.9 17.6 61.0 57.0 46.2 46.8 34.9
Red cell distribution width: % increase at extremis 56.7 36.5 57.6 77.9 79.3 68.9 93.5 50.0
Platelets (counts/ml): Pre-infection level 461 281 307 330 331 457 266 374 341
Platelets: % reduction at 32 dpi 38.8 7.7 71.7 99.1 77.6 78.1 68.8 53.5 76.2
Platelets: % reduction at extremis 76.4 30.0 78.5 82.8 98.0 89.1 97.9 94.4
Mean platelet volume (fl): pre-infection values 7 6.3 6.9 7 7.7 7.6 6.7 7.3 6.3
Mean platelet volume: % increase at 32 dpi 17.1 23.8 50.7 87.4 53.2 NDA 55.3 17.1 54
Mean platelet volume : % increase at extremis 45.7 47.6 60.9 49.4 55.3 NDA 41.1 85.7
Key: dpi = days post infection; T.b.r. = Trypanosoma brucei rhodesiense; a = Laboratory number of monkey; F = Female; M=Male; O = observed; NO=Not observed;
fl = femtolitres; pg = picograms; g/dl = grams per decilitre; 2=decreased; += increased; NDA=No data available.
doi:10.1371/journal.pntd.0000238.t003
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inoculation site mounts a reaction characterized by a marked
infiltration with polymorphonuclear leucocytes [21–22]. The
immune reaction generated at the chancre is responsible for
development of specific immunity against the variable antigen type
of metacyclics [23].
The finding that the severity of the clinical disease differed
between individual monkeys that were infected with the same
strain emphasized the likely role of host immunity on disease
outcome. The ability/inability of the host to control parasitaemia
and its effect on disease duration is further indicated by the
observation that parasitaemia patterns showed more fluctuation
(clearly marked waves) in individuals with longer disease duration
than in those with shorter durations (Figure 1). A similar trend was
observed in mice (data not shown), consistent with previous reports
[11]. In our study, clone 3801 produced a more acute disease,
while clone 3928 manifested the most chronic disease; the other
two clones were intermediate. These observations suggest that the
parasites have intrinsic properties that, in part, determine
virulence. Host factors also contribute to the disease profile, as
evidence from variations in animals infected with the same clone
indicates. A study of a number of isolates from eastern Uganda by
Smith and Bailey [24] in mice showed that distinct acute and
chronic strains of T. b. rhodesiense circulate in the focus and each
strain is related to a given zymodeme. However, apart from
individual parasite variations there were no features that could
distinguish the Ugandan from Kenyan isolates. This supports the
view that the four strains used in this study belong to the same
endemic focus characterized by pockets of specific zymodemes
with distinct clinical manifestations [24]. Similar diversities in
clinical manifestations have been observed in HAT patients
infected with T. b. rhodesiense [25] and T.b. gambiense [26] showing
that animal models accurately mirror the situation in humans
Haematology results showed that anaemia developed early in
the monkey infections; the decline in relevant parameters was
detected as early as 8 dpi. However, the rate of decline of RBC
and associated parameters was much slower than in T. brucei
infected mice in which the numbers of circulating erythrocytes can
fall by up to 50% within a week after infection [27]. Anaemia is a
common occurrence in both T. b. rhodesiense and T. b. gambiense
forms of sleeping sickness [15–16,26,28], similar to the case in
vervet monkeys. However, determination of the rates of decline of
RBC and associated parameters, is not possible in humans since
neither the date of infection nor the pre-infection values in
individual patients are known. The type of anaemia reported in
our study, microcytic hypochromic, was different from the
normocytic anaemia observed in T. brucei infected mice [29] or
Nigerian mongrel dogs [30] during the acute phase of T. b. brucei
infection. Microcytic hypochromic anaemia has previously been
associated with iron deficiency [31] and could perhaps be related
to failure of iron incorporation into red cell precursors or
inefficient recovery of iron from the phagocytosed RBC, features
which are common during acute trypanosomiasis [32]. Determi-
nation of the type of anaemia found in infected humans is
complicated by presence of concurrent infectious and nutritional
conditions [29]. This is compounded by the lack of appropriate
haematology analysers in endemic areas, and has therefore not
been systematically determined to our knowledge.
The severe progressive thrombocytopaenia reported in our
study mirrors that found in other T.b. rhodesiense animal models
[30] and human cases of sleeping sickness [28]. These findings
indicate that unlike in mild cases of iron deficiency anaemia that
are accompanied by thrombocytosis, the anaemia of trypanoso-
miasis in both humans and animals is severe and could be related
to a deficit in the production of thrombopoetin [33]. Similarly,
leukocyte changes are broadly consistent with findings from other
non–human primate studies [3–4] and humans [17]. However, the
strong granulocyte response that coincided with the day of first
detection of trypanosomes in peripheral blood (median= 4 dpi)
has not been reported before, perhaps due to the lower frequency
of sampling employed in other studies. Importantly, the presence
of multiple peaks of white cells during the course of the infection
suggests that in spite of the widely reported immunosuppressive
effects of trypanosome infections, myeloid precursor cells retain
Figure 2. Changes in the mean corpuscular volume (MCV)
mean corpuscular haemoglobin (MCH) and Red cell distribu-
tion width (RDW) in two vervet monkeys (N-554 and n-555)
that were infected with T.b. rhodesiense KETRI 3928. Panel A:
MCV; Panel B: MCH; and Panel C: RDW. Note that while both MCV and
MCH decreased below pre-infection levels and remained low through-
out; RDW increased throughout the infection.
doi:10.1371/journal.pntd.0000238.g002
Figure 3. Changes in total and differential white blood cell
numbers in vervet 554 that was infected with T.b. rhodesiense
KETRI 3928. During the early part of the infection, granulocytes and
lymphocytes are approximately equal while later in the infection,
lymphocytes are clearly the predominant cell type. (X- Total WBC, m-
lymphocytes, n-Granulocytes, &-Monocytes).
doi:10.1371/journal.pntd.0000238.g003
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the ability to proliferate in response to dominant parasite VSG’s
expressed during the course of the disease. This is in agreement
with findings that some bone marrow stem cells survive the
damage caused by trypanosomes and retain the ability to
repopulate the animal [34] and may account for the observa-
tion of very late stage leucocytosis in some individuals but not
others.
The first evidence of trypanosomes in the CSF was on day 16
(range 8–40) days (Table 2). This event is recognised by WHO [6]
as a definitive marker for the onset of late stage infection. The
timing of CSF parasitosis was largely similar to earlier observations
in the syringe passage monkey infections where the blood-brain-
barrier (BBB) was breached within 7–21 days [8,35]. Clone 3928
produced the most chronic infection of all isolates and, in monkey
554, was only detected in the CSF on day 40 after infection. Some
T. b. rhodesiense isolates from south-eastern Africa foci and some
from eastern Uganda have been reported to cause a chronic HAT
infection in humans, taking relatively long to invade the CNS
[24,36]. One of the recognized markers of CNS pathology is the
presence of raised numbers of leucocytes in the CSF above the
background (pre-infection) levels [6,8,37–38]. Indeed, there was
positive linear association between trypanosomes in the CSF and
white cell changes, suggesting that both events are primarily
determined by a single cause, possibly damage to the blood-brain
barrier. The numbers of trypanosomes in CSF increased
dramatically as disease progressed, and clinical symptoms of
disease necessitated individuals to be removed from the study on
ethical grounds, marking the terminal stage.
The results of this study establish a cyclic T. b. rhodesiense model
that more closely resembles the East African form of HAT.
Although T. b. gambiense causes a more insidious slowly
developing disease, the essential features including fever, loss of
appetite, headache, fatigue, weight loss, leg paresthesis, gait
difficulties and daytime somnolence are similar to symptoms
observed in patients infected with T. b. rhodesiense [18,39]. Thus,
this disease model in which the infection is induced using the bite
Table 4. Blood white cell changes in vervet monkeys infected with T.b. rhodesiense cloned strains through cyclic (tsetse; Glossina
pallidipes) transmission.
Parameters T.b. rhodesiense KETRI 3741
T.b. rhodesiense KETRI
3801
T.b. rhodesiense. KETRI
3804
a476F a515M a536M a523F a579M a556F a574M a554F a555M
Total white cell counts
(6103 )/ml of blood
0 dpi 8 3.4 4.4 5.8 6.6 7.4 6 11.4 5.4
4 dpi 5.2 4.1 4.7 8.4 5.9 12.2 NDA 12.5 6.2
8 dpi 5.5 1.8 3.2 2.6 4.6 4.8 4 6.2 5.1
12 dpi 5.8 2.7 2.8 NDA 4.4 8.4 6.3 5 4.3
32 dpi 5.4 4.8 4.4 NDA NDA 8.1 8.2 8.3 NDA
terminal 3.9 3.4 3.9 2.9 3.8 16.6 3.6 15.5 4.8
Lymphocytes counts
(6103)/ml of blood
0 dpi 5.6 (70) 2.2 (65) 2.4 (55) 4.2 (72) 4 (61) 4.6 (62) 3 (50) 7 (61) 2.9 (54)
4 dpi 3.7b (71) 0.8b (20) 1.2b (26) 5.1b (61) 1.9 (32) 1.8b (15) NDA 6.4 (51) 1.7b (27)
8 dpi 3.7 (67) 0.7 (39) 1.5 (47) 1 (39) 0.6b (13) 1.8b (38) 1.7 (43) 3.1b (50) 1.3b (26)
12 dpi 4 (69) 1.3 (48) 1.2 (43) NDA 1.2 (27) 3.7 (44) 3.2 (51) 1.8b (36) 1.7 (40)
32 dpi 2.7 (50) 1.7 (35) 2.6 (60) NDA NDA 5.3 (65) 4.7 (57) 6.2 (75) NDA
Terminal 2.1 (54) 2.1 (62) 2.1 (53) 1.4 (48) 1.7 (45) 8 (48) 1.6 (44) 12.6 (81) 3 (63)
Monocytes counts
(6103)/ml of blood
0 dpi 1.1 (14) 0.3 (9) 1 (22) 0.5 (9) 1.6 (24) 1.6 (22) 1.5 (25) 3 (26) 1.5 (28)
4 dpi 1 (19) 0.3 (7) 0.5 (11) 0.9 (11) 0.4 (7) 0.5 (4) NDA 2.7 (22) 0.2 (3)
8 dpi 0.4 (7) 0.4 (22) 1 (31) 0.3 (12) 0.5 (11) 0.8 (17) 0.8 (20) 0.8 (13) 0.9 (18)
12 dpi 0.8 (14) 0.4 (15) 0.3 (10) NDA 0.5 (11) 0.3 (4) 1 (16) 1.1 (22) 0.8 (19)
32 dpi 1.1 (20) 1 (21) 1 (24) NDA NDA 1.1 (14) 1.4 (17) 0.3 (4) NDA
Terminal 0.7 (18) 0.2 (5) 1.2 (31) 0.2 (7) 1.1 (29) 3.9 (24) 1.1 (31) 0.8 (5) 0.7 (15)
Granulocytes counts
(6103)/ml of blood
0 dpi 1.3 (16) 0.8 (25) 1.1 (24) 1.1 (19) 1 (15) 1.2 (16) 1.5 (25) 1.5 (13) 1.1 (20)
4 dpi 0.6 (12) 3 (74) 3 (65) 2.4 (29) 3.6 (61) 9.8 (80) NDA 3.3 (26) 4.2 (68)
8 dpi 1.4 (26) 0.7 (38) 0.7 (23) 1.3 (50) 3.6 (78) 2.3 (48) 1.6 (40) 2.3 (37) 2.9 (57)
12 dpi 1 (17) 1 (36) 1.3 (47) NDA 2.7 (61) 4.3 (51) 2.1 (33) 2.2 (44) 1.8 (42)
32 dpi 1.6 (30) 2.1 (44) 0.7 (16) NDA NDA 1.7 (21) 2.1 (26) 1.8 (22) NDA
Terminal 1.2 (31) 1.2 (34) 0.7 (17) 0.8 (28) 1 (26) 4.7 (28) 0.9 (25) 3.6 (23) 1.2 (25)
Key: dpi = days post infection; T.b.r. = Trypanosoma brucei rhodesiense; a = Laboratory number of monkey; b = value corresponding to the prepatent period; F = female;
M=male; O = observed; NO=not observed; NDA=No data available; Numbers in parentheses: cell type expressed as a % of the total white cell count at each time point.
doi:10.1371/journal.pntd.0000238.t004
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of a single fly can better represent the complex pathogenesis of
of a single fly can better represent the complex pathogenesis of
natural HAT. This model allows more precise timing of events,
such as date of infection, and the clinical and haematology
features that follow. Consequently, it is hoped that the new
model will gain application and facilitate studies that require
good precision.
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